A Study to Learn About Abrocitinib in Adult Patients With Moderate to Severe Atopic Dermatitis.

NCT05689151 · clinicaltrials.gov ↗
RECRUITING
Status
183
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Pfizer